A 12-week dose-escalating study of etelcalcetide (ONO-5163/AMG 416), a novel intravenous calcimimetic, for secondary hyperparathyroidism in Japanese hemodialysis patients [0.03%]
一项为期12周的剂量递增研究：特立卡塞（ONO-5163/AMG 416），一种新型静脉注射拟钙剂，用于日本血液透析患者的继发性甲状旁腺功能亢进症治疗
Keitaro Yokoyama,Masafumi Fukagawa,Takashi Shigematsu et al.
Keitaro Yokoyama et al.
Aims: To evaluate dose-escalation of etelcalcetide (ONO-5163/AMG 416), a novel, intravenous (IV), long-acting calcium-sensing receptor agonist, for treatment of secondary hyperparathyroidism (SHPT) in Japanese hemodialysi...
Clinical Trial
Clinical nephrology. 2017 Aug;88(2):68-78. DOI:10.5414/CN108974 2017
Acute kidney injury in critically-ill adult patients with seasonal influenza infection [0.03%]
重症流感成人患者的急性肾损伤风险预测模型及发病机制研究
Ana Dovč,Vladimir Premru,Blaž Pečavar et al.
Ana Dovč et al.
Background: Acute kidney injury (AKI) occurs in 22.4 - 100% of critically-ill hospitalized patients with influenza infection. In up to 2/3, it is severe enough to necessitate renal replacement therapy. We aimed to documen...
Anticoagulation assessment methods in plasma exchange with regional citrate anticoagulation: evaluation of post-filter and filtered plasma ionized calcium [0.03%]
局部枸橼酸抗凝血浆置换术的评估方法：滤后及滤出液离子钙的测定
Manja Antonič,Jakob Gubenšek,Jadranka Buturović-Ponikvar et al.
Manja Antonič et al.
Aim: To assess the possibility of using filtered plasma instead of postfilter ionized calcium (iCa) for the assessment of anticoagulation in plasma exchange (PE) with citrate anticoagulation. ...
Randomized Controlled Trial
Clinical nephrology. 2017;88(13):53-56. DOI:10.5414/CNP88FX13 2017
Effects of paricalcitol on biomarkers of inflammation and fibrosis in kidney transplant recipients: results of a randomized controlled trial [0.03%]
派卡利醇对肾移植受者的炎症和纤维化生物标志物的影响：随机对照试验结果
Manca Oblak,Gregor Mlinšek,Aljoša Kandus et al.
Manca Oblak et al.
Aims: Paricalcitol, a selective vitamin D activator, decreases proteinuria and may reduce graft failure risk in kidney transplant recipients. In this study, we evaluated the effect of paricalcitol on renin-angiotensin sys...
Randomized Controlled Trial
Clinical nephrology. 2017;88(13):119-125. DOI:10.5414/CNP88FX26 2017
Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center [0.03%]
硼替佐米和/或利妥昔单抗治疗肾移植后抗体介导的排斥反应与标准方案的比较：斯洛文尼亚国家中心的报道
Teja Oblak,Jelka Lindič,Jakob Gubenšek et al.
Teja Oblak et al.
Background: The aim of our study was to determine outcomes of standard treatment of antibody-mediated rejection (ABMR) of kidney grafts as compared to the addition of bortezomib or rituximab. ...
Comparative Study
Clinical nephrology. 2017;88(13):91-96. DOI:10.5414/CNP88FX21 2017
Rituximab for the treatment of membranous nephropathy: a single-center experience [0.03%]
利妥昔单抗治疗膜性肾病的疗效及安全性分析：单中心报告
Andreja Aleš Rigler,Alexander Jerman,Aleša Orsag et al.
Andreja Aleš Rigler et al.
Background: Treatment of idiopathic membranous nephropathy with rituximab was introduced more than a decade ago following experimental data that suggested involvement of B-cell-mediated reactions in its pathogenesis. It w...
The role of single nucleotide polymorphisms of CYP3A and ABCB1 on tacrolimus predose concentration in kidney transplant recipients [0.03%]
CYP3A和ABCB1单核苷酸多态性在肾移植受者他克莫司给药浓度中的作用研究
Gregor Mlinšek,Vita Dolžan,Katja Goričar et al.
Gregor Mlinšek et al.
Background: Tacrolimus has a narrow therapeutic drug window but high inter- and intrapatient variability. Our aim is to construct a model able to predict optimal maintenance tacrolimus predose concentration (C0) in kidney...
Outcome of polyomavirus nephropathy in renal transplant patients: a single-center experience [0.03%]
肾移植患者多瘤病毒肾病结局及危险因素分析（单中心报告）
Nika Kojc,Andreja Aleš Rigler,Gregor Mlinšek et al.
Nika Kojc et al.
Background: Reduction of immunosuppression is a common therapeutic strategy in patients with polyomavirus nephropathy (PVN) but may be associated with acute rejection. This study aimed to evaluate the morphology of PVN in...
Prevalence and risk factors for nonvertebral bone fractures in kidney transplant recipients - a single-center retrospective analysis [0.03%]
肾移植受者非椎骨骨折的患病率及危险因素-单中心回顾性分析
Alexander Jerman,Jelka Lindič,Andrej Škoberne et al.
Alexander Jerman et al.
Background: Complex and longstanding bone disease superimposed by harmful influences of immunosuppression is the reason for increased risk of bone fracture in kidney transplant recipients. The aim of our study was to anal...
Acute granulomatous interstitial nephritis and acute rejection in a kidney transplant recipient after zoledronic acid therapy - a case report and review of the literature [0.03%]
唑来磷酸治疗后肾移植患者急性肉芽肿性间质性肾炎和急排反应的个案报道及文献复习
Nuša Avguštin,Damjan Kovač,Nika Kojc et al.
Nuša Avguštin et al.
Background: Acute granulomatous interstitial nephritis (AGIN) in native kidneys is most commonly linked to drugs. In allografts, it is a rare complication, and it occurs mostly with infections. ...
Case Reports
Clinical nephrology. 2017;88(13):97-100. DOI:10.5414/CNP88FX22 2017